Synthesis of a Pyridoazepine Scaffold via Rhodium-Catalyzed Ring Expansion and Nitroacetamide CondensationORGANIC PROCESS RESEARCH & DEVELOPMENTIF3.52023-01-170PRE
First-in-Human Evaluation of 18F-PF-06445974, a PET Radioligand That Preferentially Labels Phosphodiesterase-4BJOURNAL OF NUCLEAR MEDICINEIF9.12022-06-307OA
Discovery of Small-Molecule CD33 Pre-mRNA Splicing ModulatorsACS MEDICINAL CHEMISTRY LETTERSIF42022-01-0410OA
PDE10A Inhibitors-Clinical Failure or Window Into Antipsychotic Drug Action?FRONTIERS IN NEUROSCIENCEIF3.22021-01-2031OAAI
Discovery of Potent and Selective Periphery-Restricted Quinazoline Inhibitors of the Cyclic Nucleotide Phosphodiesterase PDE1JOURNAL OF MEDICINAL CHEMISTRYIF6.82018-05-0226OAAI
Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor (vol 60, pg 5673, 2017)JOURNAL OF MEDICINAL CHEMISTRYIF6.82018-04-060PREAI
Identification of a Potent, Highly Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor Clinical CandidateJOURNAL OF MEDICINAL CHEMISTRYIF6.82018-01-1621PREAI
The Discovery of a Novel Phosphodiesterase (PDE) 4B-Preferring Radioligand for Positron Emission Tomography (PET) ImagingJOURNAL OF MEDICINAL CHEMISTRYIF6.82017-10-0928PREAI
Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A InhibitorJOURNAL OF MEDICINAL CHEMISTRYIF6.82017-06-1626PREAI
Dopamine D3/D2 Receptor Antagonist PF-4363467 Attenuates Opioid Drug-Seeking Behavior without Concomitant D2 Side EffectsACS CHEMICAL NEUROSCIENCEIF3.92016-10-2120OAAI
Chemoproteornics Demonstrates Target Engagement and Exquisite Selectivity of the Clinical Phosphodiesterase 10A Inhibitor MP-10 in Its Native EnvironmentACS CHEMICAL BIOLOGYIF3.82014-10-2024PREAI
Design and Selection Parameters to Accelerate the Discovery of Novel Central Nervous System Positron Emission Tomography (PET) Ligands and Their Application in the Development of a Novel Phosphodiesterase 2A PET LigandJOURNAL OF MEDICINAL CHEMISTRYIF6.82013-05-28166PREAI
Current Landscape of Phosphodiesterase 10A (PDE10A) InhibitionJOURNAL OF MEDICINAL CHEMISTRYIF6.82012-08-1491PREAI
Discovery of Novel, Potent, and Selective Inhibitors of 3-Phosphoinositide-Dependent Kinase (PDK1)JOURNAL OF MEDICINAL CHEMISTRYIF6.82011-11-2328PREAI
Use of Structure-Based Design to Discover a Potent, Selective, In Vivo Active Phosphodiesterase 10A Inhibitor Lead Series for the Treatment of SchizophreniaJOURNAL OF MEDICINAL CHEMISTRYIF6.82011-06-0854PREAI
Diastereoselective Synthesis of 2,3,6-Trisubstituted PiperidinesJOURNAL OF ORGANIC CHEMISTRYIF3.62009-05-1417PRE
Discovery of a series of 6,7-dimethoxy-4-pyrrolidylquinazoline PDE10A inhibitorsJOURNAL OF MEDICINAL CHEMISTRYIF6.82006-12-22128PREAI